$AMWL

HIRSCHHORN MARK sold $56K of AMWL

HIRSCHHORN MARK (Chief Financial Officer) sold 4,282 shares of American Well Corp (AMWL) at $13.00 on 2026-10-01.

Original reporting
SEC EDGAR · HIRSCHHORN MARK
Published Oct 5, 2026, 9:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMWL
Neutral
high confidence
Mentioned
$AMWL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

The disclosed sale is unlikely to affect price materially, but it adds to the data set for monitoring insider behavior.

02

Market read

A routine insider sale with limited trading impact; useful for compliance monitoring but low trading relevance.

03

What to watch

The CFO's remaining stake remains sizable, indicating continued confidence in the company.

Relevance 3/10Novelty 3/10Timing: post-market

Background

Form 4 filings provide the first public disclosure of insider transactions, offering transparency to investors.

Company-level read

Ticker impact

$AMWLNeutralHigh confidence
Context

CFO Hirschhorn Mark sold 4,282 shares of American Well Corp for $55,666, reducing his stake to 223,906 shares.

Expected impact

slight downward pressure as the market prices the insider sell.

Evidence & confidence

Sale size is small relative to float and typical trading volume; no broader implications disclosed.

Market effects

Minimal impact on the telehealth sector; the sale does not signal a change in business outlook.

No regional effect; the transaction is company‑specific.

Limited relevance; only investors tracking insider activity may note the sale.

Counterpoint

Some traders may view any insider sell as a bearish signal, but the modest size suggests no material concern.

Key entities

  • American Well Corp

    US‑listed telehealth provider (ticker AMWL).

  • Hirschhorn Mark

    Chief Financial Officer of American Well Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMWLMedAI 8/10

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.

$AMWLMed

American Well Corp (AMWL): AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026 BOSTON, August 4 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30, 2026

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $2.2M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 103,684 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $20.92 ($20.80–$21.09, $2.17M total) across 3 trades over 2026-10-02 to 2026-10-06. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Zolezzi William (10% owner), Divisadero Street Partners, L.P. (10% owner) and Divisadero Street Capital, LLC (10% owner).